Conftused about which technology vendor to use for your business problem? Ask for help Close






twoXAR is a software-driven drug discovery company. They leverage their computational platform to identify promising drug candidates, validate & de-risk them through preclinical studies, and progress candidates to the clinic through industry and investor partnerships. twoXAR is financially backed by Andreessen Horowitz and the Stanford-StartX Fund and engaged in collaborations with leading academic research and biopharma R&D organizations.

Biological Data Extraction: Sourcing, normalizing, and identifying disease signals in biological data sets.
Automated Model Generation: Automatically generating a mathematical drug-disease model.

Feature Identification: Extracting relevant factors from the model to guide drug classification.
Candidate Analysis: Candidate analysis and classifying the efficacy of each drug using machine learning.

Contact Details
Stay Ahead of the Machine Learning Curve

At Emerj, we have the largest audience of AI-focused business readers online - join other industry leaders and receive our latest AI research, trends analysis, and interviews sent to your inbox weekly.

Thanks for subscribing to the Emerj "AI Advantage" newsletter, check your email inbox for confirmation.